Holly Schachner

Holly Schachner, MD, is a highly experienced medical professional currently serving as Chief Medical Officer at Deerfield Management since September 2023. Dr. Schachner has played pivotal roles in various organizations, such as Applied Molecular Transport, where responsibilities include serving as a Board Member and Lead Independent Director, mentoring executive leaders, and guiding clinical strategy. Prior positions include Senior Vice President of Clinical Development at NorthSea Therapeutics, Chief Medical Officer at DoubleRainbow Biosciences, and Senior Vice President at MyoKardia, with a significant focus on clinical portfolios and therapeutic innovations across diverse medical fields. Dr. Schachner's career spans key leadership roles at Allergan, Sanofi, Bayer HealthCare, Pfizer, and an academic appointment at Columbia University Irving Medical Center, showcasing a strong background in pediatrics and pediatric endocrinology. Dr. Schachner's educational credentials include an MD from Stony Brook University and a residency and fellowship in Pediatrics and Pediatric Endocrinology from the Icahn School of Medicine at Mount Sinai.